|
|
|
|
|
17.01.26 - 13:12
|
UK supermarkets go all out for ′Jab-uary′ with food for those on weight-loss drugs (The Guardian)
|
|
|
M&S, Morrisons and Ocado among retailers bringing out ranges targeting shoppers taking Wegovy or similarVeganuary and dry January are among the new year health kicks enthusiastically endorsed by supermarkets, but this year the buzz is around “Jab-uary” as pricey diet foods aimed at people on weight-loss drugs hit the shelves.Marks & Spencer, Morrisons, Asda, Ocado and the Co-op are among the big names targeting shoppers who use weight-loss injections, known as GLP-1 agonists, but better known by brand names such as Wegovy and Mounjaro. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.01.26 - 11:06
|
Richard Thaler on the mentality of spending money (Bloomberg)
|
|
|
Barry speaks with Richard Thaler and Alex Imas award winning economists and co-authors of "The Winner's Curse: Behavioral Economics Anomalies". They discuss the psychology of spending at auctions, and the effects of draft picks on NFL team spending. They also discuss the anomalies of human behavior and decision making that challenge classical economic theories.
Listen to the people, ideas and conversations that shape markets on the Masters in Business podcast:
Apple: http://bit.ly/43wa4F4
Spotify: http://bit.ly/3qj7LqO
Anywhere: http://bit.ly/3OPAL3n (Source: Bloomberg)...
|
|
|
17.01.26 - 11:06
|
Alex Imas and Richard Thaler on Learning Behavioral Economics (Bloomberg)
|
|
|
Barry speaks with Richard Thaler and Alex Imas award winning economists and co-authors of "The Winner's Curse: Behavioral Economics Anomalies". They discuss the psychology of spending at auctions, and the effects of draft picks on NFL team spending. They also discuss the anomalies of human behavior and decision making that challenge classical economic theories.
Listen to the people, ideas and conversations that shape markets on the Masters in Business podcast:
Apple: http://bit.ly/43wa4F4
Spotify: http://bit.ly/3qj7LqO
Anywhere: http://bit.ly/3OPAL3n
(Source: Bloomberg)...
|
|
|
|
|
17.01.26 - 11:01
|
STEICO Aktie: Prelims 2025 - Operatives Ergebnis übertrifft Guidance und Prognose (Aktiencheck)
|
|
|
Hamburg (www.aktiencheck.de) - STEICO-Aktienanalyse von der Montega AG:
Patrick Speck, Aktienanalyst der Montega AG, stuft in einer aktuellen Aktienanalyse die Aktie der STEICO SE (ISIN: DE000A0LR936, WKN: A0LR93, Ticker-Symbol: ST5) unverändert mit "kaufen" ein.
STEICO habe jüngst vorläufige Zahlen zum Geschäftsjahr 2025 veröffentlicht, die umsatzseitig leicht unter, ergebnisseitig aber über der Analystenprognose gelegen hätten. [mehr]...
|
|
|
|
|
|
|
|